New imaging combo could help surgeons spot hidden head and neck cancer
NCT ID NCT05945875
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 27 times
Summary
This early-stage trial tests whether combining two imaging techniques can help surgeons better detect and remove head and neck cancer. About 40 adults with squamous cell carcinoma will receive a radioactive tracer before surgery and a fluorescent dye during surgery to highlight cancer cells. The goal is to see if this approach is safe and improves the removal of all cancer tissue.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Vanderbilt University/Ingram Cancer Center
RECRUITINGNashville, Tennessee, 37203, United States
Contact
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.